生物标志物在临床脑刺激自适应调控中的新兴作用
本综述探讨了生物标志物在治疗性脑刺激自适应调控中的应用前景。文章阐述了生物标志物可用于术中电极定位、动态优化设备效能及自动调整刺激参数,并列举了从生理活动到影像信号等多种潜在标志物类型。核心问题是基于生物标志物的自适应系统能否优化刺激效率与疗效,并强调神经外科医生在转化中的关键作用及标志物验证标准的重要性。
要点
- 生物标志物可辅助术中定位电极、动态优化刺激参数并推动自动调控。
- 潜在标志物涵盖生理活动、病理活动、影像及光遗传信号等多种类型。
- 自适应系统能否提升疗效尚待验证,标志物开发与验证标准至关重要。
核心结论
- 基于生物标志物的自适应脑刺激调控有望优化设备效能与疗效,并深化对病理神经网络的理解。
- 神经外科医生在生物标志物研发与临床转化中处于前沿地位。
- 建立生物标志物的开发与验证标准对自适应刺激技术的临床推广至关重要。
研究设计与样本
- 综述性文章,旨在更新通过相关生物标志物实现刺激调控的新方法。
- 未报告系统检索范围或纳入研究数量。
主要发现
- 生物标志物可反映疾病状态,理论上能辅助术中电极定位、动态控制设备效能并最终指导刺激参数的自动调整。
- 用于控制颅外或颅内刺激的生物标志物涵盖连续生理脑活动、间歇病理活动、触发局部现象或电位、可穿戴设备信号、血流、生化或心脏信号、温度扰动、光学或磁共振成像变化以及光遗传信号。
- 关键问题包括基于生物标志物的自适应系统能否优化效率并最终提升疗效、作为刺激调整的输入,以及拓宽对病理状态下异常神经网络的基本理解。
临床怎么用
- 神经外科医生可探索将生物标志物整合到脑刺激系统中,以改进电极定位和刺激参数调整。
- 临床实践中需关注生物标志物的开发与验证标准,以推动自适应刺激方法的应用。
局限性
- 本文为综述,未报告原始研究数据或系统评价方法。
- 未具体说明各类生物标志物的敏感性、特异性或临床验证结果。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Therapeutic brain stimulation has proven efficacious for treatment of nervous system diseases, exerting widespread influence via disease-specific neural networks. Activation or suppression of neural networks could theoretically be assessed by either clinical symptom modification (ie, tremor, rigidity, seizures) or development of specific biomarkers linked to treatment of symptomatic disease states. For example, biomarkers indicative of disease state could aid improved intraoperative localization of electrode position, optimize device efficacy or efficiency through dynamic control, and eventually serve to guide automatic adjustment of stimulation settings. Biomarkers to control either extracranial or intracranial stimulation span from continuous physiological brain activity, intermittent pathological activity, and triggered local phenomena or potentials, to wearable devices, blood flow, biochemical or cardiac signals, temperature perturbations, optical or magnetic resonance imaging changes, or optogenetic signals. The goal of this review is to update new approaches to implement control of stimulation through relevant biomarkers. Critical questions include whether adaptive systems adjusted through biomarkers can optimize efficiency and eventually efficacy, serve as inputs for stimulation adjustment, and consequently broaden our fundamental understanding of abnormal neural networks in pathologic states. Neurosurgeons are at the forefront of translating and developing biomarkers embedded within improved brain stimulation systems. Thus, criteria for developing and validating biomarkers for clinical use are important for the adaptation of device approaches into clinical practice.
引用
- Hoang KB, Turner DA. The Emerging Role of Biomarkers in Adaptive Modulation of Clinical Brain Stimulation. Neurosurgery. 2019. PMID: 30957145. doi:10.1093/neuros/nyz096
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。